Related references
Note: Only part of the references are listed.Serum anti-amyloid-β antibodies and Alzheimer's disease in elderly Korean patients
M. S. Song et al.
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2007)
Evaluation of the safety and immunogenicity of synthetic Aβ42 (AN1792) in patients with AD
AJ Bayer et al.
NEUROLOGY (2005)
Mechanisms of action of IVIg and therapeutic considerations in the treatment of acute and chronic demyelinating neuropathies
MC Dalakas
NEUROLOGY (2002)
Patients with Alzheimer disease have lower levels of serum antiamyloid peptide antibodies than healthy elderly individuals
ME Weksler et al.
EXPERIMENTAL GERONTOLOGY (2002)
Reduced levels of amyloid β-peptide antibody in Alzheimer disease
Y Du et al.
NEUROLOGY (2001)
Share Paper
